These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38965630)

  • 1. 6-Bromo quinazoline derivatives as cytotoxic agents: design, synthesis, molecular docking and MD simulation.
    Emami L; Hassani M; Mardaneh P; Zare F; Saeedi M; Emami M; Khabnadideh S; Sadeghian S
    BMC Chem; 2024 Jul; 18(1):125. PubMed ID: 38965630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Elwan A
    Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and cytotoxic evaluation of quinazoline derivatives bearing triazole-acetamides.
    Pedrood K; Taayoshi F; Moazzam A; Iraji A; Yavari A; Ansari S; Sajjadi-Jazi SM; Mohajeri-Tehrani MR; Garmsiri N; Haghpanah V; Soleymanibadi M; Larijani B; Hamedifar H; Adibpour N; Mahdavi M
    Heliyon; 2023 Feb; 9(2):e13528. PubMed ID: 36873155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation, and computational studies of some novel quinazoline derivatives as anticancer agents.
    Emami L; Khabnadideh S; Faghih Z; Farahvasi F; Zonobi F; Gheshlaghi SZ; Daili S; Ebrahimi A; Faghih Z
    BMC Chem; 2022 Nov; 16(1):100. PubMed ID: 36419100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2.
    Shaker AMM; Shahin MI; AboulMagd AM; Abdel Aleem SA; Abdel-Rahman HM; Abou El Ella DA
    Bioorg Chem; 2022 Dec; 129():106143. PubMed ID: 36191430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Molecular Dynamics Simulation, and
    Nili Ahmadabadi M; Rezaee E; Nematpour M; Karami L; Mokhtari S; Kobarfard F; Tabatabai SA
    Iran J Pharm Res; 2022 Dec; 21(1):e133840. PubMed ID: 36915409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
    El-Adl K; Ibrahim MK; Alesawy MSI; Eissa IH
    Bioorg Med Chem; 2021 Jan; 30():115958. PubMed ID: 33360576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SARs study of novel spiro-oxindoles as potent antiproliferative agents with CDK-2 inhibitory activities.
    Al-Jassas RM; Islam MS; Al-Majid AM; Nafie MS; Haukka M; Rahman AFMM; Alayyaf AMA; Barakat A
    Arch Pharm (Weinheim); 2023 Aug; 356(8):e2300185. PubMed ID: 37253118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and mechanistic studies of novel imidazo[1,2-a]pyridines as anticancer agents.
    Ismael AS; Amin NH; Elsaadi MT; Abdel-Rahman HM
    Bioorg Chem; 2022 Nov; 128():106042. PubMed ID: 35878430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Bromoquinazoline Derivatives as Potent Anticancer Agents: Synthesis, Cytotoxic Evaluation, and Computational Studies.
    Zare S; Emami L; Behrouz M; Khankahdani RA; Nickpour S; Emami M; Faghih Z; Khabnadideh S
    Chem Biodivers; 2023 Jul; 20(7):e202201245. PubMed ID: 37191970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanochemical Synthesis and Molecular Docking Studies of New Azines Bearing Indole as Anticancer Agents.
    Ibrahim MS; Farag B; Al-Humaidi JY; Zaki MEA; Fathalla M; Gomha SM
    Molecules; 2023 May; 28(9):. PubMed ID: 37175279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green, facile synthesis and evaluation of unsymmetrical carbamide derivatives as antimicrobial and anticancer agents with mechanistic insights.
    Sroor FM; Soliman AAF; Youssef EM; Abdelraof M; El-Sayed AF
    Sci Rep; 2024 Jul; 14(1):15441. PubMed ID: 38965246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme.
    El-Adl K; El-Helby AA; Sakr H; Eissa IH; El-Hddad SSA; M I A Shoman F
    Bioorg Chem; 2020 Sep; 102():104059. PubMed ID: 32653608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some novel hybrid quinazoline-based heterocycles as potent cytotoxic agents.
    Malekzadeh M; Dadkhah S; Khodarahmi GA; Asadi P; Hassanzadeh F; Rostami M
    Res Pharm Sci; 2022 Feb; 17(1):22-34. PubMed ID: 34909041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, computational study and cytotoxic evaluation of some new quinazoline derivatives containing pyrimidine moiety.
    Zare S; Emami L; Faghih Z; Zargari F; Faghih Z; Khabnadideh S
    Sci Rep; 2023 Sep; 13(1):14461. PubMed ID: 37660139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
    Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
    Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
    Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE
    Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
    Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
    Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.